Cargando…

Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions

Human papillomavirus (HPV) is the most prevalent sexually transmitted virus globally. Persistent high‐risk HPV infection can result in cervical precancerous lesions and cervical cancer, with 70% of cervical cancer cases associated with high‐risk types HPV16 and 18. HPV infection imposes a significan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Jiatian, Zheng, Lan, He, Yuedong, Qi, Xiaorong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501338/ https://www.ncbi.nlm.nih.gov/pubmed/37719443 http://dx.doi.org/10.1002/mco2.368

Ejemplares similares

Distribution of human papillomavirus genotypes in cervical lesions
por: Ma, Li, et al.
Publicado: (2017)

Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
por: Nayereh, Khadem Ghaebi, et al.
Publicado: (2012)

Human Papillomavirus in Brazilian women with and without cervical lesions
por: Oliveira-Silva, Michelle, et al.
Publicado: (2011)

Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus
por: Lourenço de Freitas, Natália, et al.
Publicado: (2021)

Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer
por: Jung, Hun Soon, et al.
Publicado: (2015)

The Role of Long Noncoding RNAs in Human Papillomavirus-associated Pathogenesis
por: Sharma, Surendra, et al.
Publicado: (2020)

Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion
por: Ravilla, Rahul, et al.
Publicado: (2019)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing
por: Marchadier, Agathe, et al.
Publicado: (2023)

Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions
por: Zhu, Jiang, et al.
Publicado: (2021)

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009)

Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions
por: Feng, Ting, et al.
Publicado: (2023)

Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.
por: Mutirangura, A., et al.
Publicado: (1998)

Human Papillomavirus Coinfection in the Cervical Intraepithelial Lesions and Cancer of Mexican Patients
por: Padilla-Mendoza, Juan Ramón, et al.
Publicado: (2020)

The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study
por: He, Zuoxi, et al.
Publicado: (2022)

Distribution of human papillomavirus genotypes in women with high-grade cervical intraepithelial lesions and cervical carcinoma and analysis of human papillomavirus-16 genomic variants
por: Karadža, Magdalena, et al.
Publicado: (2021)

Carcinogenesis and management of human papillomavirus-associated cervical cancer
por: Kusakabe, Misako, et al.
Publicado: (2023)

Risk of human papillomavirus infection and cervical intraepithelial lesions in Chinese renal transplant recipients
por: Chen, Ming, et al.
Publicado: (2022)

Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea
por: García-Espinosa, Benjamín, et al.
Publicado: (2009)

Human Papillomavirus 16 Non-European Variants Are Preferentially Associated with High-Grade Cervical Lesions
por: Freitas, Luciana Bueno, et al.
Publicado: (2014)

Distribution of Carcinogenic Human Papillomavirus Genotypes and Association to Cervical Lesions among Women in Fez (Morocco)
por: Souho, Tiatou, et al.
Publicado: (2016)

The DNA load of six high-risk human papillomavirus types and its association with cervical lesions
por: Del Río-Ospina, Luisa, et al.
Publicado: (2015)

Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition
por: Liu, Jun, et al.
Publicado: (2020)

Association between asymptomatic sexually transmitted infections and high-risk human papillomavirus in cervical lesions
por: Wang, Lei, et al.
Publicado: (2019)

Association of HLA-G 3′ UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections
por: Xu, Hui-Hui, et al.
Publicado: (2018)

Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China
por: Zhao, Jin, et al.
Publicado: (2017)

Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections
por: Bekkers, R L M, et al.
Publicado: (2003)

Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions
por: Li, Kemin, et al.
Publicado: (2015)

Distribution of Human Papillomavirus Genotypes in Iranian Women According to the Severity of the Cervical Lesion
por: Salehi-Vaziri, Mostafa, et al.
Publicado: (2016)

The association between endometriosis and risk of endometrial cancer and breast cancer: a meta-analysis
por: Ye, Jiatian, et al.
Publicado: (2022)

Pathogenesis of allergic diseases and implications for therapeutic interventions
por: Wang, Ji, et al.
Publicado: (2023)

Human Papillomavirus and Cervical Cancer
por: Unger, Elizabeth R., et al.
Publicado: (2004)

Prevalence of Human Papillomavirus Type 58 in Women With or Without Cervical Lesions in Northeast Brazil
por: Fernandes, JV, et al.
Publicado: (2013)

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya
por: De Vuyst, H, et al.
Publicado: (2012)

Human Papillomavirus Infection and Risk Determinants for Squamous Intraepithelial Lesion and Cervical Cancer in Japan
por: Sasagawa, Toshiyuki, et al.
Publicado: (1997)

Cervical Carcinosarcoma: Current Understanding on Pathogenesis, Diagnosis, Management and Future Perspectives
por: Shu, Xinyao, et al.
Publicado: (2021)

The Interaction of Human Papillomavirus Infection and Prostaglandin E(2) Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics
por: García-Quiroz, Janice, et al.
Publicado: (2022)

Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention
por: Zhou, Jing, et al.
Publicado: (2023)

Therapeutic Vaccine Strategies against Human Papillomavirus
por: Khallouf, Hadeel, et al.
Publicado: (2014)

The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions
por: Dovnik, Andraž, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2rotmdcbd36j37a69aikmglc0q